ReviewCell proliferation2022

Manufacturing clinical-grade human induced pluripotent stem cell-derived beta cells for diabetes treatment.

Lay Shuen Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.